Publish in this journal
Journal Information
Vol. 73. Issue 4.
Pages 327 (April 2020)
Vol. 73. Issue 4.
Pages 327 (April 2020)
ECG Contest
Full text access
ECG, April 2020
ECG de abril de 2020
Sara Lozano Jiménez
Corresponding author

Corresponding author:
, Jorge Toquero Ramos, Xabier Cía Mendioroz
Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
Related content
Rev Esp Cardiol. 2020;73:40910.1016/j.rec.2019.10.020
Sara Lozano Jiménez, Jorge Toquero Ramos, Xabier Cía Mendioroz
This item has received
Article information
Full Text
Download PDF
Figures (1)
Full Text

The patient was a 53-year-old woman with congenital heart disease consisting of partial atrioventricular septal defect, corrected in infancy. In light of severe symptomatic mitral valve regurgitation, the mitral valve was replaced with a mechanical prosthetic valve. During the postoperative period, complete atrioventricular block occurred. As this persisted 6 days after the intervention, it was decided to implant a dual-chamber pacemaker, initially programmed in DDDR mode at a minimum frequency of 60 bpm.

Immediately after implantation, the Arrhythmias Unit was alerted due to a paced rhythm at 45 bpm, with the following ECG recorded (figure 1).

Figure 1

What do you think was the most likely diagnosis?

  • 1.

    T-wave oversensing

  • 2.

    Switch to DDI mode due to detection of atrial tachyarrhythmia

  • 3.

    Wenckebach behavior on exceeding the maximum tracking rate

  • 4.

    Sinus tachycardia with 2:1 ventricular pacing due to atrial sensing during the postventricular atrial refractory period

Submit your answer to The answer will be published in the next issue (May 2020). #RetoECG.

Copyright © 2019. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?